Company intelligence / Profile preview

A10 Lab

Ownership: Private
Development stage: Commercial

Overview

A10 Lab has developed a digital peer support and habit-building app, MinChallenge/Minchalle, which has over one million users in Japan. The app initially focused on diabetes but now supports behavioral change across metabolic diseases and addiction. It leverages small group motivation to drive sustained health-related behavior change.

Therapeutic areas: Metabolic DisordersPsychiatryOther
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on A10 Lab.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on A10 Lab.

Explore the full profile